Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 Diabetes.

ABSTRACT:

Importance

Prices for newer analogue insulin products have increased. Lower-cost human insulin may be effective for many patients with type 2 diabetes.

Objective

To evaluate the association between implementation of a health plan-based intervention of switching patients from analogue to human insulin and glycemic control.

Design, setting, and participants

A retrospective cohort study using population-level interrupted times series analysis of members participating in a Medicare Advantage and prescription drug plan operating in 4 US states. Participants were prescribed insulin between January 1, 2014, and December 31, 2016 (median follow-up, 729 days). The intervention began in February 2015 and was expanded to the entire health plan system by June 2015.

Exposures</

SUBMITTER: Luo J 

PROVIDER: S-EPMC6439763 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature